Select Scientific Publications
-
-
-
Cell Discovery
-
-
-
Company Activities & Updates
New Presentation
October 23, 2024
ExoMira co-founder Dr. Huiping Liu chaired and presented at the 26th Lynn Sage Symposium, showcasing CTC-based strategies for targeting metastatic breast cancer.
AACR Presentation
April 9, 2024
ExoMira Co-Founder Dr. Huiping Liu presented on CTC plasticity and dormancy at a major AACR 2024 symposium, advancing visibility of the company’s science.
New Presentation
November 2023
The Exomira Medicine-Northwestern University team proudly presented their multi-line inventions and dual-targeting onco-immunotherpy technologies at Chicago Biomedical Consortium Biocapital Summit at Fulton Market, Chicago, IL.
New Publication
May 2023
Congratulations to ExoMira CSO Dr. Andrew Hoffmann and the team under the supervision of ExoMira cofounders Drs. Fang and Liu at Northwestern University published the single-cell RNA seq research article on COVID-19 immunity in Clinical Immunology (05-17-2023).
New Involvement
April 2023
ExoMira co-founder Dr. Huiping Liu at Northwestern University was inducted as an elected member to American Society for Clinical Investigation (ASCI).
New Ecosystem
April 2023
New Chan Zuckerberg Biohub Chicago will become a neighbor of ExoMira Medicine at the Fulton Labs.